Advanced cancers destined to recur after treatment with single drugs that 'target' tumor cells: study
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, ...
Jun 13, 2012
0
0